Characteristics of Non Diabetic Hyperglycemic Inpatients

Sponsor
John H. Stroger Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00842010
Collaborator
(none)
600
1
33.1
18.2

Study Details

Study Description

Brief Summary

This retrospective nested non-matched case control study compared patients directly admitted to the General Medicine Wards, not transferred from ICU with

  • hyperglycemia on admission but no previous diagnosis of diabetes

  • diabetic hyperglycemic patients

  • non hyperglycemic non diabetic patients from the same nested population.

The investigators' hypothesis is that the clinical characteristics and endpoints of the non diabetic hyperglycemics should be similar to the diabetic population and different from the non diabetic non hyperglycemic population.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    600 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Hyperglycemic Non Diabetic (HND) Hospital Patients: Are They Different From Diabetic Hyperglycemic and Non-Hyperglycemic Non-Diabetic(NHND) Patients?
    Study Start Date :
    Mar 1, 2006
    Actual Primary Completion Date :
    Dec 1, 2007
    Actual Study Completion Date :
    Dec 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    HND

    Patients with hyperglycemia, without previous diagnosis of diabetes

    DH

    Patients that have previous diagnosis of Diabetes Mellitus

    NHND

    Patient with NO previous diagnosis of diabetes, and no hyperglycemia

    Outcome Measures

    Primary Outcome Measures

    1. Length of stay [Measured 24 hours after patient is discharged. From day 1 of admission until day of discharge]

    2. Inpatient Mortality [From day 1 of admission until day of discharge]

    Secondary Outcome Measures

    1. Frequency of SIRS on admission [Measures obtained 24 hours after patient is discharged. Clinical data obtained on day 1 of admission]

    2. Frequency of inpatient infection [From day 1 of admission until day of discharge]

    3. Rate of use of intravenous glucose drip [From day 1 of admission until day of discharge]

    4. Frequency of steroid use [From day 1 of admission until day of discharge]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Admitted to John H. Stroger Jr. Hospital

    • Admitted to Internal Medicine Service from March-April 2006 and in October 2007

    Exclusion Criteria:
    • Transfer from any intensive care unit (medical or surgical)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 John H. Stroger Jr. Hospital Chicago Illinois United States 60612

    Sponsors and Collaborators

    • John H. Stroger Hospital

    Investigators

    • Principal Investigator: Evelyn Lacuesta, MD, John H. Stroger Jr. Hospital
    • Study Chair: Jyothsna Palla, MD, John H. Stroger Jr. Hospital
    • Study Chair: Yannis Guerra, MD, Rush University Hospital, John H. Stroger Jr. Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00842010
    Other Study ID Numbers:
    • HNDJHS200902
    First Posted:
    Feb 12, 2009
    Last Update Posted:
    Feb 12, 2009
    Last Verified:
    Feb 1, 2009
    Keywords provided by , ,

    Study Results

    No Results Posted as of Feb 12, 2009